Xenon’s XEN1101 for focal epilepsy has likely positive Phase II, but doubt on ability to produce …,

Trial design raises experts’ eyebrows. Based on existing clinical and preclinical data, an epilepsy researcher who has advised Xenon on XEN1101 …, Trial design raises experts’ eyebrows. Based on existing clinical and preclinical data, an epilepsy researcher who has advised Xenon on XEN1101 …, Read More

Scroll to Top